Efficacy and pharmacologic data of second-generation tyrosine kinase inhibitor nilotinib in BCR-ABL-positive leukemia patients with central nervous system relapse after allogeneic stem cell transplantation
Mark Reinwald, Eberhard Schleyer, Philipp Kiewe, Igor Wolfgang Blau, Thomas Burmeister, Stefan Pursche, Martin Neumann, Michael Notter, Eckhard Thiel, Wolf Karsten Hofmann, Hans Jochem Kolb, Stefan Burdach, Hans Ulrich Bender
Research output: Contribution to journal › Article › peer-review
27Scopus
citations
Fingerprint
Dive into the research topics of 'Efficacy and pharmacologic data of second-generation tyrosine kinase inhibitor nilotinib in BCR-ABL-positive leukemia patients with central nervous system relapse after allogeneic stem cell transplantation'. Together they form a unique fingerprint.